Intrauterine Devices

Use of an intrauterine vacuum-induced hemorrhage control device led to rapid and effective bleeding control for vaginal and cesarean births, according to real-world study results published in Obstetrics & Gynecology.

There was a significant increase in the use of long-acting reversible contraception among adolescents after the AAP recommended it almost a decade ago, according to findings published in JAMA Pediatrics.

In a survey sent to women about midlife care, almost half of the respondents reported negative health care interactions. Only 18% reported positive or satisfying health care interactions.

AUSTIN, Texas — Although reproductive health represents a unique challenge in patients with lupus, success is possible with careful planning and consideration, said a presenter at the 2023 Rheumatology Nurses Society annual conference.

Levonorgestrel 52 mg IUD reduces blood loss by more than 90% over 6 months among women with severe heavy menstrual bleeding, according to results of a prospective trial published in Obstetrics & Gynecology.

For premenopausal women with endometrial intraepithelial neoplasia, use of conservative treatment with progestin increased and hysterectomy declined from 2008 to 2020, researchers reported.

Early IUD placement at 2 to 4 weeks postpartum was noninferior to placement at 6 to 8 weeks postpartum for expulsion, but not partial expulsion, according to a randomized noninferiority trial published in JAMA.

BALTIMORE — New phase 3 data demonstrate efficacy of an investigational next-generation, hormone-free, low-dose copper IUD for prevention of pregnancy through 3 years of use.

SAN DIEGO — Internal medicine physicians “really share the responsibility” for patients seeking contraception, according to Pelin Batur, MD, FACP, NCMP.

Although about half of primary care physicians who treat Medicaid patients offered oral contraceptives, just 10% provided longer-acting birth control methods like intrauterine devices, according to researchers.